A rare case of symmetrical drug‐related intertriginous and flexural erythema with tamoxifen use

Abstract

Key Clinical MessageSymmetrical drug‐related intertriginous and flexural erythema is characterized by a diffuse symmetric rash of the gluteal and intertriginous areas with only one published report of association with tamoxifen. It is imperative for clinicians to recognize tamoxifen‐induced SDRIFE to avoid life‐threatening dermatologic complications, which can be resolved with discontinuation of tamoxifen.